GetTopicDetailResponse(id=3103e2015e1, topicName=皮膚型狼瘡, introduction=皮膚型狼瘡, content=null, image=null, comments=1, allHits=1136, url=https://h5.medsci.cn/topic?id=72015, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=9380, tagList=[TagDto(tagId=9380, tagName=皮膚型狼瘡)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1248030, encodeId=91bf12480304b, content=抗<a href='/topic/show?id=8d601046934b' target=_blank style='color:#2F92EE;'>#BDCA2#</a>抗體<a href='/topic/show?id=cb83104694d3' target=_blank style='color:#2F92EE;'>#Litifilimab#</a>對(duì)<a href='/topic/show?id=257ae692755' target=_blank style='color:#2F92EE;'>#系統(tǒng)性紅斑狼瘡#</a>的治療作用，對(duì)<a href='/topic/show?id=3103e2015e1' target=_blank style='color:#2F92EE;'>#皮膚型狼瘡#</a>同樣效果很好，未來會(huì)成為通用的靶點(diǎn)了。, objectTitle=NEJM：抗BDCA2抗體Litifilimab對(duì)系統(tǒng)性紅斑狼瘡的治療作用（LILAC研究）, objectType=article, longId=738583, objectId=9adbe3858308, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220901/73e90b9a257149debde240aad8657382.jpg, objectUrl=/article/show_article.do?id=9adbe3858308, replyNumber=0, likeNumber=207, createdTime=2022-09-09, rootId=0, userName=小小醫(yī)者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9adbe3858308, moduleTitle=NEJM：抗BDCA2抗體Litifilimab對(duì)系統(tǒng)性紅斑狼瘡的治療作用（LILAC研究）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9adbe3858308)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
